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A B S T R A C T
Amyotrophic Lateral Sclerosis (ALS) is a neural disorder gradually leading to paralysis of the whole body.
Alterations in superoxide dismutase SOD1 gene have been linked with several variants of familial ALS. Here, we
investigated a transgenic (Tg) cloned swine model expressing the human pathological hSOD1G93A allele. As in
patients, these Tg pigs transmitted the disease to the progeny with an autosomal dominant trait and showed ALS
onset from about 27months of age. Post mortem analysis revealed motor neuron (MN) degeneration, gliosis and
hSOD1 protein aggregates in brainstem and spinal cord. Severe skeletal muscle pathology including necrosis and
inflammation was observed at the end stage, as well. Remarkably, as in human patients, these Tg pigs showed a
quite long presymptomatic phase in which gradually increasing amounts of TDP-43 were detected in peripheral
blood mononuclear cells. Thus, this transgenic swine model opens the unique opportunity to investigate ALS
biomarkers even before disease onset other than testing novel drugs and possible medical devices.
1. Introduction
Amyotrophic Lateral Sclerosis (ALS) is an adult-onset neurodegen-
erative disorder affecting both upper and lower motor neurons (MNs).
Mutations in the gene coding for the antioxidant enzyme Cu, Zn-su-
peroxide dismutase 1 (SOD1) occur in 10%–20% of familial ALS (FALS)
cases and in up to 7% of sporadic ALS (SALS) cases (Andersen, 2006;
Rosen, 1993).> 150 different mutations, mostly dominant inherited,
have been identified in ALS patients. These findings enabled the sub-
sequent development of novel experimental animal models: currently
ALS research relies heavily on transgenic rodents expressing mutant
human SOD1 (hSOD1). Accordingly, a MN disease phenotype results
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from the expression of gain-of-function of different hSOD1 mutants in
rodents, rather than SOD1 gene targeting (Turner and Talbot, 2008).
These animal models contributed to the discovery of several pathoge-
netic mechanisms underlying the disease including axonal transport
defects, oxidative stress, protein misfolding, mitochondrial dysfunction,
excitotoxicity and altered RNA metabolism (Peviani et al., 2010),
nevertheless the molecular mechanisms responsible for the selective
MN degeneration are not yet fully elucidated. The lack of translation
from bench to bedside represents a major drawback against this animal
model (Benatar, 2007; Perrin, 2014). Several factors are supposed to be
involved in the discrepancy between the results obtained in mouse
models and patients including phylogenetic distance among species,
size, lifespan and subtle differences of anatomical structures and phy-
siology. Recent meta-analysis of drug trials in mice revealed that sev-
eral studies were underpowered and most treatments were applied at
pre-symptomatic stage, whereas treatments of ALS patients start only
months or even years after the onset of the disease (Perrin, 2014). In-
terestingly, it has been suggested that the onset of clinical symptoms is
preceded by a long pre-symptomatic period in which there is a system
dysfunction but not clinical manifestations due to an intrinsic reserve
within the neuromuscular system or recruitment of compensatory me-
chanisms (Eisen, 2014; Talbot, 2014). Understanding what happen
during the long time elapsed between the onset of the pathological
process triggered by the gene mutation and the onset of overt symp-
tomatic disease has important implications as this phase is likely to be
the best target for therapeutic trials. A critical issue is developing an
ALS animal model which recapitulate the long preclinical/clinical
phases as in patients, to allow the identification and validation of pre-
symptomatic diagnostic biomarkers and biotargets for effective ther-
apeutic interventions. In this respect, pigs which have a long lifespan
and have been employed for modeling several human diseases in-
cluding neurodegenerative disorders (Holm et al., 2016; Lind et al.,
2007) may present advantages as compared to rodent models. As such,
a hSOD1G93A transgenic (Tg) swine was generated by somatic cell nu-
clear transfer (SCNT) of primary porcine adult male fibroblasts stably
expressing the pathological allele of the human SOD1 gene carrying the
glycine-to-alanine conversion at the 93rd codon (G93A) (Chieppa et al.,
2014).
Here, we showed that hSOD1G93A Tg swine shares several features
of ALS at the symptomatic phase. Moreover, the disease is transmissible
to the progeny with mendelian traits. Contrary to the rodent models,
these Tg pigs have a quite long pre-symptomatic phase of about
27months of age, which is a relevant pathological feature in common
with patients.
Furthermore, we investigated TDP-43, a major neuropathological
hallmark of ALS (Neumann, 2009). In spinal cord of ALS patients, TDP-
43 pathology is most commonly observed in sporadic cases, but it has
also been detected in mutant-SOD1 familial cases and mouse models
(Lauranzano et al., 2015; Marino et al., 2015; Sumi et al., 2009). In-
creasing amounts of the total TDP-43, which parallel disease progres-
sion, were found in peripheral blood mononuclear cells (PBMCs) of
sporadic ALS patients (Filareti et al., 2017; Nardo et al., 2011). Ac-
cordingly, a progressive TDP-43 raise was also observed in PBMCs of
hSOD1G93A Tg swine before the onset of the symptomatic phase. All
together these findings suggest that the hSOD1G93A Tg pigs represent a
remarkable ALS model and may strongly contribute to further support
clinical research of ALS.
2. Materials and methods
2.1. Animals and breeding
All procedures were conducted as described by the institutional
guidelines that are in accordance with national (D.L. no. 116, G.U.
suppl. 40, February 18, 1992, no. 8, G.U., 14 luglio 1994; D.L.26/2014)
and international laws and policies (EEC Council Directive 86/609, 63/
2010, OJ L 358, December 12, 1987; National Institutes of Health Guide
for the Care and Use of Laboratory Animals, US National Research
Council, 1996). hSOD1G93A Tg pigs were produced as previously re-
ported (Chieppa et al., 2014). Among the four Tg cloned founder pigs
(168, 174, 204, 205) that reached adulthood, Tg 168 was bred to es-
tablish a transgenic line and Tg 168 progeny was further investigated.
The specific number of animals or samples used was stated in the figure
captions. All experiments were designed to minimize the number of
animals used and their discomfort (project authorization n 1043/2016-
PR from Ministry of Health).
2.2. qPCR
To determine the transgene copy number the 2−ΔΔct method was
applied, using genomic human DNA as a calibrator. The qPCR was
performed using the iTaq Universal Sybr Green Supermix (Bio-Rad) and
the following primers pair: SOD1Fw (5′-catgaacatggaatccatgcagg-3′)
and SOD1Rw (5′-taatggaccagtgaaggtgtg-3′) for the human SOD1 gene
and gapdhFW (5′-tgccacccagaagactgtgg-3′) and gapdhRW (5′-ac-
cttgcccacagccttggc-3′) for the glyceraldehyde-3-phosphate dehy-
drogenase as housekeeping gene. The program set on a Mx3000P
thermocycler (Stratagene) consists of forty cycles composed of a de-
naturation step at 95 °C for 10 s followed by an annealing/extension
step at 62 °C for 30 s. Data were presented as delta cycle threshold (ΔCt)
between the SOD1 and housekeeping gene. The ΔCt values in Tg pigs
and calibrator DNA were converted to relative transgene copy number
by the equation 2−ΔΔCt.
2.3. RT-PCR
To determine MCP-1 mRNA levels total RNA was extracted from
cervical spinal cord using the Trizol method (Invitrogen) and purified
with PureLink RNA columns (Thermo Fisher Scientific). Real-time PCR
was performed using the Taq Man Gene expression assay (Applied
Biosystems) following the manufacturer's instructions, on 50 ng of
cDNA specimens in triplicate, using 1× Universal PCR master mix
(Thermo Fisher Scientific) and 1× mix containing the specific porcine
probe for MCP1 (Ss03394377_m1; Thermo Fisher Scientific). Relative
quantification was calculated from the ratio between the cycle number
(Ct) at which the signal crossed a threshold set within the logarithmic
phase of MCP1 gene and that of the reference β-actin gene
(Ss03376081_u1; Thermo Fisher Scientific). Mean values of the tripli-
cate results for each animal were used as individual data for 2−ΔΔCt
analysis.
2.4. Fluorescent in situ hybridization (FISH)
FISH experiments were carried out as previously described on in-
terphase and metaphase cells from three Tg founder pigs (168, 174,
204) (Paulis et al., 2015). Tg 205 was not analyzed since it was a Tg
204-clone. Briefly, cell cultures were treated with KaryoMAX colcemid
(Thermo Fisher Scientific) at a final concentration of 0.1 μg/ml for 2 h
at 37 °C and cells were then detached by treatment with 0.25% trypsin/
EDTA (Lonza). After hypotonic treatment with 0.075M KCl and fixation
in methanol: acetic acid (3:1 v/v), the cell suspension was dropped onto
a slide and air dried. Slides were treated with 0.004% Pepsin (Sigma
Aldrich) at 37 °C for 10 s and dehydrated through the ethanol series
before denaturation in 70% formamide/2xSSC. The hSOD1G93A DNA
vector was used as DNA probe. The DNA was labeled via nick transla-
tion (Enzo Life Sciences), using Bio-11-dUTP (Roche Diagnostics) and
resuspended in hybridization buffer (50% formamide, 10% dextran
sulphate, 1× Denhart's solution, 0.1% SDS, 40mM Na2HPO4 pH 6.8,
2xSSC) containing 10× Salmon Sperm DNA. Before hybridization the
probes were denatured at 80 °C for 10min and pre-annealed at 37 °C for
20min. Hybridization was carried out overnight at 37 °C. Stringent
washings were performed in 50% formamide/2xSSC at 42 °C. For biotin
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detection, the slides were incubated with FITC-conjugated avidin DCS
(Vector Laboratories), then with biotin-conjugated anti avidin D anti-
body (Vector Laboratories) and finally with FITC-conjugated avidin
DCS. Avidin and all the antibodies were used at a final concentration of
5 μg/ml. Slides were mounted in Vectashield mounting medium with
DAPI (Vector Laboratories), and then were scored under an Olympus
BX61 Research Microscope equipped with a cooled CCD camera.
Images were captured and analyzed with Applied Imaging Software
CytoVision (CytoVision Master System with Karyotyping & FISH). To
identify individual chromosomes and to assign the location of signals to
specific chromosome regions, inverted digital images of DAPI banded
chromosomes were used. For each sample at least 20 metaphases and
100 interphase nuclei were analyzed.
2.5. Splinkerette assay
The splinkerette ligation-mediated PCR was applied, as described in
(Potter and Luo, 2010). Briefly, the oligonucleotides SPLNK-BOT2 (5′- cga
agagtaaccgttgctaggagagaccgtggctgaatgagactggtgtcgacactagtgg -3′) and
SPLNK-AATT-ApoI (5′-aattccactagtgtcgacaccagtctctaattttttttttcaaaaaaa-3′)
were annealed to generate the ApoI splinkerette linker. In parallel,
genomic DNA (gDNA) of the Tg 168 founder was purified with standard
procedure based on sodium dodecyl sulphate lysis supplemented with
proteinase K followed by rounds of phenol and chloroform extractions.
Purified gDNA was then ApoI digested and an aliquot (about 200 ng) was
ligated with a 10-fold molar excess ApoI-splinkerette linker in a volume of
about 50 μl. Ligated DNA was then amplified by three rounds of nested-
PCR with v3-F1 (5′- cattaattgcgttgcgctcactgc-3′), v3-F2 (5′-
ggtttgcgtattgggcgctcttc-3′) and v3-F2 (5′- ggtttgcgtattgggcgctcttc-3′) out-
ward primers targeting the 3′ end of the integrated vector and the SPL-S1
(5′- cgaagagtaaccgttgctaggagagacc-3′) and SPL-S2 (5′- gtggctgaatga-
gactggtgtcgac-3′) primers targeting the ApoI-splinkerette linker. The chi-
meric plasmidic-genomic amplified DNA was then sequenced by standard
procedure. Next, undigested Tg 168 gDNA template was amplified with
the v3-F1, v3-F2 and v3-F3 outward primers together with the g3-R1 (5′-
ctccagtctcttacttcacccaactc-3′), g3-R2 (5′- gcatcttcttagtctcagagcctcaaacc-3′)
and g3-R3 (5′gataaatgttctcctgcacctattaatg-3′) to prove that the vector is
indeed contiguous with the isolated 3′ flanking sequence. The primers
targeting the 3′-flanking sequence gDNA, g3-R1, g3-R2 and g3-R3 were
also coupled with the g5-F1 (5′- ggaattaggagggtttggaaatagaactc-3′), g5-F2
(5′- ggatagtcagcacatgcaacactgcattc-3′) and g5-F3 (5′- gaggatcactggtttaa-
tagggtgtagag-3′) primers targeting the 5′ flanking sequence of the
genomic breakpoint to demonstrate that only one sister chromosome 2
was targeted by the tandem integration of the vectors into the Tg 168
genome.
2.6. Neurological examination
Neurologic examination was performed monthly by a veterinary
neurologist. An examination protocol was properly developed and
adapted to the pigs and followed the standard procedure for assessing
mental status, posture, gait, postural reactions and proprioception,
cranial nerves, spinal reflexes and sensitivity.
2.7. Motor function analysis
Pigs underwent a qualitative and quantitative digital gait analysis
(3D Motion Capture system, 3DMC), using a 3D computerized system
with 2 cameras. A stereoscopic video system was used to analyze the
qualitative biomechanics of the pig gait strategy. The two camcorders
were placed on two tripods with a height of 50 cm from the ground and
with a parallelism between the focal axes. The binocular vision system
was designed to record 10m panoramic field of view. An audio trigger
system was used to synchronize the camcorders. Surface electro-
myography (sEMG) signals were detected from gastrocnemius and ti-
bialis anterior simultaneously with video recordings. For each muscle,
myoelectric activity was recorded in bipolar configuration with a pair
of surface electrodes (1.2 cm2, 3 cm inter-electrode distance; Kendall)
positioned over the muscle belly. Prior to electrode positioning the skin
region was shaved, abraded and cleaned with alcohol to improve the
mechanical and electrical stability of the electrode-skin contact. The
synchronization between sEMG signals and videos was ensured by a
custom-made video trigger. This device was positioned in the field of
view of the camera. The video trigger generates a flashing light in
correspondence of the start and the end of sEMG acquisition. The video
frames corresponding to the beginning and the end of the sEMG ac-
quisition can be identified, thus allowing the offline re-alignment of
sEMG and video recordings. The motor function protocol consisted in a
set of gait tasks. The animal was free to walk in a linear trajectory along
a 5m asphalted sidewalk. When the pig arrived to the finish of the
sidewalk, it turned around and came back to start a new gait cycle. Gait
tasks were recorded, in a forward direction and in a return direction. A
specialized operator controlled the direction of the gait and assisted the
animal during the turning phase with a manual bulkhead. Video and
sEMG signals were analyzed using a custom-written software in Matlab
(R2016a, The MathWorks Inc.). Raw sEMG signals were bandpass fil-
tered (30 Hz to 500 Hz, 4th order non-causal Butterworth filter). EMG
envelopes were obtained by full-wave rectification and low pass fil-
tering (cutoff frequency= 5Hz, 2nd order non-causal Butterworth
filter) of raw EMGs. EMG envelopes of individual muscles were seg-
mented in time in N epochs corresponding to the duration of the gait
cycle. The gait cycle was defined as the time interval between two
successive contacts of the right-posterior paw. Ground contacts of each
paw were visually assessed by the investigators with an accuracy of± 1
video frame (i.e. 40 ms, being 25 Hz the frame rate of the camera).
Segmented sEMG epochs were normalized in time by interpolating data
points over a time base of 1000 points for each gait cycle (Courtine
et al., 2005) and by fitting the data with a cubic spline to (Thorup et al.,
2008). Eventually, the obtained profiles of sEMG activity during the
normalized gait cycle were averaged for each muscle.
2.8. Histology and immunohistochemistry
Pigs were sacrificed according to the approved protocol of animal
welfare. Brain and spinal cord were rapidly dissected out and formalin
immersion-fixed for histology/immunohistochemistry or 4% PFA im-
mersion-fixed for immunofluorescence analysis. Tissues were then
paraffin embedded or crioprotected in 30% sucrose and OCT em-
bedded, respectively. For histological analysis 5 μm sections were
stained with hematoxylin and eosin (H&E). Immunostaining was per-
formed with the following antibodies: anti Golgi Complex (1: 50,
Abcam, ab103439), anti GFAP (1: 100, Millipore, MAB 3402), anti Iba1
(1: 600, Biocare, CP290A), anti Cleaved Caspase-3 (1: 150, Cell
Signaling Technology, 9661), anti Microtubule associated proteins 1A/
1B light chain 3, LC3 (1:200, Sigma-Aldrich, L8918), anti human SOD1
(1: 600, Abcam, ab 79,390), anti SOD1 exposed dimer interface
[(SEDI), 1: 700, StressMarq Bioscineces Inc., SPC-206P], anti
Neurofilament H non-phosphorylated SMI 32 (1: 1000, Bio Legend,
SMI-32R), anti-Neurofilaments, phosphorylated SMI 31 (1: 5000, Bio
Legend, SMI-31R), anti peripherin (1: 1000, Millipore, AB 1530), anti
TDP-43 (1: 1000, Proteintech, 10,782–2-AP), anti phospho TDP-43 (1:
1000, Cosmo Bio Co., Ltd., TIP-PTD-P02). For DAB staining, sections
were incubated 1 h at RT with biotinylated goat-anti-mouse/rabbit
(Vector Laboratories) followed by ABC reagents (Vector Laboratories)
and developed with DAB reagent (Sigma Aldrich). For immuno-
fluorescence staining, sections were incubated with Alexa Fluor -con-
jugated secondary antibodies (1: 1000, Thermo Fischer Scientific) for
1 h at RT and counterstained with DAPI (1: 1000, KPL, 71–03-01). For
the terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) assay, the DeadEnd Colorimetric TUNEL System Kit
(Promega) was used according to the manufacturer's protocol.
Biopsy tissue obtained from several muscles was precooled in
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isopentane and frozen in liquid nitrogen. Frozen muscle cross sections
of 8 μm thickness were produced and routine histological and enzyme
activity analyses of the sections were conducted: H&E, Gomori tri-
chrome (MGT), periodic acid Schiff staining (PAS), succinate dehy-
drogenase (SDH), nicotinamide adenine dinucleotide tetrazolium re-
ductase (NADH-TR), cytochrome oxidase (COX), and adenosine
triphosphatase (ATPase).
2.9. Motor neuron analyses
For MNs quantification, a series of one-in-ten sections (50 μm apart)
through different levels of the entire spinal cord, for each animal was
analyzed. At least 6 Cresyl violet (CV) stained sections per spinal cord
level were analyzed. Only neurons with a mean diameter ≥25 μm and
prominent nuclei and nucleoli and located in the anterior horn of the
spinal cord, were counted using a 40× objective under a light micro-
scope (Leica Microsystems). For the count of LC3-positive puncta visible
into the MN soma, the samples were observed with a Leica TCS SP5
confocal laser scanning microscope (Leica Microsystems) to create 3D
reconstructions. Confocal stacks were analyzed by Image J software: at
least 80 MNs were evaluated and LC3-positive puncta visible into the
MN cell body were counted.
2.10. Neuromuscular junction (NMJs) analysis
Gastrocnemius and peroneus muscles were immersion-fixed in 4%
PFA for 48 h, cryoprotected in 30% sucrose and sectioned at 40 μm
thickness on a freezing microtome. NMJs were visualized using Alexa
555-conjugated α-bungarotoxin (BTX, 1: 1000, Thermo Fisher
Scientific) to label post-synaptic acetylcholine receptors and
Neurofilament (1: 50, Novocastra, NCL-l-NF200-N52) to bind MN
axons. Endplates were considered innervated if there was a complete
overlay with the axon or denervated if the endplate was not occupied
by MN terminal axons. In case of partial overlap, the NMJs were con-
sidered as partially innervated. At least 100 randomly selected end-
plates per muscle were analyzed using an epifluorescence microscope
(Nikon).
2.11. Electron microscopy
Tg and control (CTR) lumbar spinal cord segments, gastrocnemius
muscle and sciatic nerve specimens were fixed by immersion in a so-
lution containing 2.5% glutaraldehyde and 0.5% sucrose in 0.1M
Sorensen phosphate buffer, until embedding. Samples were then post-
fixed in 1% osmium tetroxide and dehydrated in ascending series of
ethanol (from 30% to 100%). After two brief passages in propylene
oxide and o/n in a mixture of propylene oxide and Glauerts mixture of
resins, specimens were embedded in Glauerts mixture of resins (50:50
Araldite M and Araldite Harter, HY 964): in the resin mixture, 0.5% of
the plasticizer dibutylphthalate was added, followed by 2% of accel-
erator 964, used to promote the polymerization of the embedding
mixture. Semi-thin (1-μm thick) sections were then cut, using a Ultracut
UCT ultramicrotome (Leica Microsystems) and stained by 1% Toluidine
blue for light microscopy examination and morphological analysis. For
transmission electron microscopy (TEM), ultra-thin sections (80-nm
thick) were cut using the Ultracut UCT ultramicrotome, and counter-
stained with Uranyl Acetate Replacement Stain (Electron Microscopy
Sciences). Ultra-thin sections were observed by a JEM-1010 TEM
(JEOL) equipped with a Mega-View-III digital camera and a Soft-
Imaging-System (SIS). Sciatic nerve samples were also examined for
morphological analysis. For the g-ratio measurement (i.e. ratio of the
inner axonal diameter to the total outer diameter), toluidine blue
stained sections of Tg and CTR sciatic nerve were analyzed: approxi-
mately 150 axons have been evaluated for each group. Fiber (i.e. axon
and myelin) and axon diameters have been measured by Neurolucida
software (MicroBrightField), using the “quick measure line” tool.
2.12. Western blotting
Protein extracts were prepared from central nervous system -CNS-
(spinal cord, brainstem, cerebellum, cortex and striatum) and muscles
homogenates. Depending on the experimental reasons to be achieved,
different extraction protocols have been used. We analyzed either so-
luble and/or triton insoluble fractions (TIF) according to (Ouyang and
Hu, 2001).
Western blotting was performed using SDS polyacrylamide gels
(NuPAGE 4–12% Bis-Tris gel or 12% Bis-Tris gel, Invitrogen) with 25 μg
of protein extract loaded per lane. PVDF membranes (Bio-Rad) were
incubated with primary antibodies raised against SOD1 (1:1000, Abcam
79,390; 1:500, Sigma Aldrich, HPA0014101), GFAP (1:1000, Millipore
MAB3402), Iba1 (1:100, Millipore MABN92) overnight at 4 °C, followed
by peroxidase-conjugated secondary antibodies. Gels were stripped and
reprobed with anti GADPH (1: 1000, Santa Cruz sc-166,574). Signals
were acquired with the ChemiDoc™ Touch Gel Imaging System.
2.13. PBMC isolation and protein extraction
PBMCs were isolated from pigs peripheral venous blood essentially
as previously described (Nardo et al., 2011). Briefly, samples of blood
were collected in EDTA pre-coated tubes (BD Vacutainer® K2EDTA) and
PBMCs were isolated from EDTA blood by Ficoll-Hypaque (Ficoll-
Plaque™ Plus, GE Healthcare) density gradient centrifugation at 800×g
for 30min at 18–20 °C. Mononuclear cells were collected from the in-
terface and washed three times with RPMI 1640 medium (EuroClone).
Platelets were eliminated by an additional wash and centrifugation at
200×g for 10min. PBMCs were stored as pellets at −80 °C. Before
analysis, PBMCs were lysed in 20mM Tris-HCl pH 7.5, 0.1% NP40 and
0.1% SDS supplemented with Protease Inhibitors (Sigma) and in-
cubated at 95 °C for 5min. Samples were centrifuged at 16.000×g for
10min at 4 °C and protein concentration in supernatants was analyzed
by the BCA protein assay (Pierce). Supernatants were analyzed by dot
blot analysis.
2.14. TDP-43 pathology by biochemical approaches
To evaluate TDP-43 aggregation, TIF was isolated from frontal
cortex and spinal cord tissues of Tg and control pigs and analyzed by
dot blot, as described (Basso et al., 2009).
To evaluate TDP-43 mislocalization in cervical spinal cord of the Tg
168 pig, TDP-43 level was measured in the nuclear and cytoplasmic
fractions in comparison with a control animal (CTR1). Subcellular
fractionation of the tissue was done as previously described
(Lauranzano et al., 2015; Pasetto et al., 2017). Mouse monoclonal anti-
GAPDH (1:10.000 dilution; Millipore) and mouse monoclonal anti-
lamin A/C (1:500 dilution; Chemicon) were used, respectively, as cy-
toplasmic and nuclear markers. Level of TDP-43 in nuclear and cyto-
plasmic fractions was analyzed by dot blot.
2.15. Dot blot analysis
Protein lysates (3 μg) from PBMC, nuclear and cytoplasmic fractions
and TIF were directly loaded onto nitrocellulose Trans-Blot transfer
membranes (Bio-Rad) by vacuum filtration, as described previously
(Nardo et al., 2011). An internal standard which is a pool of all samples
in the analysis was deposited in triplicates. Dot blot membranes were
blocked with 3% (w/v) BSA (Sigma Aldrich) and 0.1% (v/v) Tween 20
in Tris-buffered saline, pH 7.5, incubated with rabbit polyclonal anti-
TDP-43 primary antibody (1:2500 dilution; Proteintech), then with
anti-rabbit peroxidase-conjugated secondary antibody (1:5000 for IB;
Santa Cruz Biotechnology Inc.). Blots were developed with Luminata™
Forte Western Chemiluminescent HRP Substrate (Millipore) on the
ChemiDoc XRS system (Bio-Rad). Densitometry was done with Pro-
genesis PG240 v2006 software (Nonlinear Dynamics). The
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immunoreactivity of the different proteins was normalized to Ponceau
Red staining (Fluka) and to the internal standard of each membrane.
2.16. Statistical analysis
Statistical data analysis was performed using STATA 14 (Stata Corp,
College Station, TX) and GraphPad Prism 5 software (La Jolla). It was
performed a univariate analysis based on multilevel mixed-effects
linear regression models for immunoblot analysis (hSOD1, GFAP, Iba1),
MNs count and NMJs analysis, a Kolmogorov- Smirnov test for sEMG, a
Mann Whitney U test for 3DMC, an unpaired t-test for LC3-positive
puncta count, g-ratio, fiber size and myelin thickness measurements, a
chi square test for fiber size distribution analysis and a one-way ANOVA
with Tukey's multiple comparisons test for TDP-43 levels, as specified in
the figure legends. P < .05 was considered significant.
3. Results
3.1. Molecular analysis of cloned hSOD1G93A Tg pigs
Transgenic cloned founder pigs expressing the human pathological
allele hSOD1G93A were previously generated by SCNT of primary por-
cine fibroblasts and the transgene integration pattern of the ApaL1
linearized pMG5 ′ 3′ MARPuro-hSOD1 G93A plasmid vector analyzed
by Southern blot (Chieppa et al., 2014). Here, cytogenetic mapping was
carried out by fluorescent in situ hybridization (FISH) on interphase
and metaphase chromosomes of primary fibroblasts isolated from Tg
168, Tg 174, Tg 204 cloned founder pigs and a third generation (F3)
Tg168-progeny, Tg 559 pig. Single multiple transgene copies (see
below) were integrated in single genomic sites mapped on 2q24 (Tg
168), 2p11 (Tg 174) and 17q21 (Tg 204), whereas the Tg168-F3 pro-
geny, Tg 559, showed integration of the transgenic DNA on 2q24 band
of both sister chromosomes, respectively (Fig. 1a, b). By quantitative
PCR, about 20 copies of the hSOD1G93A transgene were estimated to be
integrated in tandem in the genomic site of the Tg 168 founder,
whereas about 5 copies for Tg 204 pig and even a lower copy number
for Tg 174. Since the onset of the disease was clearly evident at
27months of age in the Tg 168 founder and the disease transmitted to
the progeny (Fig. 2d), the Tg 168 transgenic line was further in-
vestigated by splinkerette ligation-mediated PCR to map at high re-
solution the genomic integration site (Fig. S1a-c).
A chimeric PCR fragment of about 700 bp was amplified from the 3′-
Fig. 1. Molecular characterization of
hSOD1G93A Tg pigs. (a) FISH analysis on
metaphase spreads obtained from fibro-
blasts of three hemizygous founders (Tg
168, 174 and 204) and one F3 homozygous
Tg168-progeny (Tg 559) using the
hSOD1G93A plasmid as probe (green).
Inserts show the chromosome ideogram and
the respective enlarged section of the me-
taphase with the hybridized chromosome.
Chromosomes were counterstained with
DAPI (blue); white arrows indicate the lo-
calization of the probe. (b) Interphase FISH
analysis on nuclei obtained from fibroblasts.
The percentage of the number of signal/
nucleus is indicated. SS: Single Signal; DS:
Double Signals; NS: No Signal. n indicates
the number of nuclei counted. (c) Schematic
representation of the PCR assay used for
genotyping the Tg 168 pig and its progeny
(see also Fig. S1). The (g5-F2; v3-R1) primer
set amplifies the 968 bp band of the trans-
genic allele, whereas the (g5-F2; g3-R2)
primer set amplifies the 763 bp band of the
endogenous wild type allele. (d)
Representative TBE-agarose gel electro-
phoresis of the PCR products, as described
in c, on gDNAs extracted from third gen-
eration (F3) pigs of the Tg 168-progeny (see
also legends of Fig. 2 and Fig. S1). (e) The
abundance of hSOD1 is compared to
GAPDH by immunoblot of samples isolated
from brain, lumbar spinal cord and skeletal
muscle of hSOD1G93A Tg cloned founder
boars. C: control. (For interpretation of the
references to colour in this figure legend,
the reader is referred to the web version of
this article.)
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end of the integrated vector joined to one of the flanking sequences of
the host genome. BLAST alignment revealed that the bp 1–309 segment
of the chimeric sequence shared 100% identity with the 3’end of the
vector, the bp 310–669 segment was 99.72% aligned on chromosome 2
with the Sus scrofa 11.1 chr2:124045533-124045892
(Ensembl release 91) (Reference Sequence NC_010444.4:
bp124045533-124045892) genomic sequence and the bp 666-674
segment shared 100% identity with the sequence of the ApoI-splinker-
ette linker.
Further PCR assays on undigested Tg 168 gDNA allowed to precisely
map at 124045533 bp the genomic breakpoint on one of the two sister
chromosomes 2 (hemizygosity) of Tg 168 and to show that the two most
external copies of the tandem repeats of the vector were in opposite
orientation.
Importantly, the integration site of Tg 168 was mapped quite far
from known coding genes about 655 kb from the FAM170A-like gene at
the 5’end and about 288 kb from the proline-rich protein 16 gene at the
3′-end, supporting the evidence that no coding genes were interrupted
by the integration event. In addition, genotype analysis of the Tg 168
progeny confirmed that the ALS disease was always associated with the
presence of integrated array of the hSOD1G93A transgenes and that the
disease was transmitted to the progeny as a dominant autosomal
mendelian trait (Figs. 1c, d and 2d). Moreover, the copy number was
stable within subsequent Tg 168 generations corresponding to about 20
copies in heterozygous pigs while homozygous pig (Tg 559) carrying
twice the number of copies as do heterozygous pigs.
Fig. 2. Phenotype of hSOD1G93A Tg pigs. (a)
Representative image of CTR and Tg 168 at
the end point (31months old) with hin-
dlimb spastic paralysis. (b) Time courses of
the EMG signal envelopes in CTR and Tg
168 symptomatic pigs. A gait pattern al-
teration (in shape and variability) is clearly
recognized in Tg 168 in both muscles for
both sides (Kolmogorov-Smirnov test,
P < .001). (c) Differences in average con-
tact time between CTR and symptomatic Tg
168 pigs (Mann Whitney U test, P < .001,
Tukey representation). (d) Family tree of
transgenic line obtained from Tg 168
founder showing that the transgene and the
ALS-like phenotype are inherited in an au-
tosomal dominant fashion. In the diagram
females are represented by circles and
males are represented by squares. A half
black-shaded symbol indicates that pig in-
herited the hSOD1G93A transgenes in hemi-
zygosis, whereas full black shaded symbol
in homozygosis; Open symbols are wild
type pigs. A slashed symbol indicates that
pig was euthanized or died suddenly. DO
(months): disease onset associated to motor
deficits or to a labored breathing; DO*
(months): indicates sudden death due to
acute respiratory failure after sedation; HE:
Euthanasia on Health (months) indicate
pigs which were sacrificed before overt
clinical symptoms; NDS: not determined
sickness (months) are pigs died for causes
other than disease or euthanized soon after
birth.
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Immunoblot analysis revealed that the amounts of the transgenic
hSOD1G93A protein in Tg 168 extracts of the brain, spinal cord and
muscles were significantly higher compared with parallel tissue sam-
ples harvested by the Tg 174, Tg 204 founder pigs. The hSOD1G93A
abundance in the Tg 168 tissues was estimated about 6-fold higher
compared with Tg 174 tissues (Fig. 1e). Lastly, the mutant hSOD1
protein amounts in the brain and spinal cord were comparable among
the different Tg 168 progeny (F1, F2 and F3; Fig. S8).
3.2. A dominant autosomal trait of ALS-like phenotype is shown in
hSOD1G93A Tg 168 swine family
Cloned hSOD1G93A Tg founder pigs developed normally with respect
to posture, gait and behavior and they reached adulthood. At 27th
months of age, Tg 168 founder boar, carrying multiple copies of the
transgene ( ̴ 20 copies) and the highest transgene expression levels,
started to show gait abnormalities. The initial clinical manifestations
were an unilateral hind limb lameness and a reduction in spontaneous
walking activity in the cage. At 28months of age, Tg 168 developed
moderate ataxia and hypermetria of hind limbs. At 29–30months of age
the neurologic phenotype progressively worsened, involving also the
front limbs and consisting in prolonged lateral recumbency and cough
during eating. At 31months of age Tg pig showed trembling when
standing, severe ataxia, spastic tetraparesis more pronounced on hind
limbs and dyspnea (Fig. 2a; Video S1, S2). This stage was established as
humane end point and therefore the Tg 168 pig was euthanised and
deeply investigated. By contrast, no further post mortem investigations
were carried out on Tg founders, Tg 174, Tg 204 and Tg 205 (Tg 204-
clone), that did not show any clinical signs of disease up to 5 years,
likely due to insufficient amount of exogenous hSOD1G93A protein to
trigger the phenotype. Surface EMG (sEMG) time courses during the
gait cycle for gastrocnemius and peroneus muscles of symptomatic Tg
168, asymptomatic Tg founder pigs (Tg 174, Tg 204, Tg 205) and an
age matched non transgenic CTR pig were performed. Qualitative and
quantitative assessment between EMG traces of the Tg 168 and CTR
pigs revealed significant differences (P < .001) suggesting a clear al-
teration of the gait pattern in both muscles bilaterally (Fig. 2b). Elec-
trophysiological analysis by sEMG exhibited a clear pattern of co-con-
traction of the gastrocnemius and peroneus muscles in Tg 168 pig at the
end stage but not in CTR pig or other asymptomatic Tg pigs. As ex-
pected, 3DMC analysis, showed that the average ground contact time of
the symptomatic Tg 168 was found greater than the CTR, to confirm
altered gait (CTR: 1.78 ± 0.07 s vs Tg 168: 2.15 ± 0.07 s; P < .001;
Fig. 2c). Analogous clinical features were observed in Tg 168 progeny,
the F1 (Tg 307), the F2 (Tg 404, Tg 405), and the F3 (Tg 559) pigs.
Interestingly, the onset of disease in homozygous Tg animal (Tg 559)
was earlier (12months) than in hemyzygous pigs (27months) (Fig. 2d).
Moreover, a subset of hemizygous Tg pigs (Tg 305, Tg 407, Tg 409, Tg
411, Tg 437) showed a labored breathing caused by respiratory muscle
weakness and a sudden death due to an acute respiratory failure (ARF)
during sedation for some clinical procedures, even in the absence of
overt motor deficits (Fig. 2d).
3.3. ALS neuropathological features are evident in hSOD1G93A Tg pigs
In end-stage Tg symptomatic pigs (Tg 168 and progeny), H&E and
CV staining of spinal cord sections showed MN shrinkage and atrophy.
By analyzing the semi-thin sections of Tg lumbar spinal cord, several
degenerating, condensed MNs were observed compared to CTR pig
(Fig. 3a, b). MNs exhibited darkened and shrunken cytoplasm, with
crenated cell membrane, consistent with degeneration (Fig. 3b). Elec-
tron microscopy images also revealed evident nuclear alterations,
characterized by presence of nucleolar cavities and electron dense
granules in Tg pig with respect to CTR pig (Fig. 3c, d). Moreover, im-
munostaining examination of MN Golgi apparatus (GA), revealed
fragmentation and reduced GA content in Tg compared to CTR pigs
(Fig. 3e, f). Quantification of CV-stained spinal cord MNs revealed a
statistically significant decrease of MN counts at cervical and thoracic
(C1-C2, T6-T8, T9-T11) levels in Tg pigs (Fig. 3g). Average differences
of MN counts in Tg pigs compared with CTR group were 52% in C1-C2
(P= .004; 95% CI 17–88%), 43% in T6-T8 (P= .017; 95% CI 8–80%)
and 42% in T9-T11 (P= .037; 95% CI 2.4–81%). A neuroinflammatory
response was observed; in end stage Tg pigs lumbar spinal cord, Iba1
and GFAP immunostaining were prominently increased compared to
CTR (Fig. 3h-k). Immunoblot analysis confirmed that Iba1 amounts
were significantly higher in Tg pigs (+112%, P < .001 95% CI
79–115%). Microgliosis was uniformly distributed in spinal cord, in-
deed no difference in protein amounts were found, considering the
spinal cord level (cervical, thoracic or lumbar; P= .871 in thoracic and
P= .233 in lumbar vs cervical spinal cord;) in Tg pigs (Fig. 3l). Esti-
mates of the mean percentage differences of GFAP expression between
Tg and CTR group was 94% (P= .01, 95% CI 22–165%) with a sta-
tistically significant increase of astrocytosis from cervical to lumbar
trait in Tg compared to CTR pigs (53%, P= .01, 95% CI 13–159% in
thoracic trait and 66%, P= .02, 95% CI 25–107% in the lumbar trait;
Fig. 3m). In line with the activated gliosis, quantitative polymerase
chain reaction analysis revealed that the proinflammatory MCP-1
mRNA levels were higher in Tg (Tg 168 and its F1 progeny, Tg 305)
than those in CTR pigs (Fig. S2).
Additionally, H&E analysis of brainstem nuclei revealed vacuoliza-
tion of the neurons and neuropil (Fig. 3n, o), peripheral neuronal
chromatolisis (Fig. 3p), focal satellitosis and neuronophagia (Fig. 3q),
in the dorsal vagal motor nucleus (DVN) and in the hypoglossal nerve
nucleus (HN). In Tg but not in CTR pigs, some MNs in spinal cord
ventral horn and brainstem nuclei were immunoreactive for cleaved
caspase-3 (CC3), (Fig. 3r, s), however no TUNEL-positive cells were
detected in CTR nor Tg pigs in the same areas (data not shown). To
evaluate the autophagy pathway in the Tg168 pig, double immuno-
fluorescence analyses of SMI32 (MN marker) and LC3 (autophagosome
marker) was performed. A huge increase of LC3-positive vesicles was
observed in Tg 168 pig MNs compared to CTR pig (CTR 27.95 ± 2.11
vs Tg 168 58.23 ± 2.72, P < .001; Fig. S3 a-h). The ultrastructure
analysis of myelinated axons of the spinal cord white matter showed
altered and disrupted myelin sheath, with disordered fiber arrangement
and lack of mitochondria in Tg pig compared to the well-organized
myelin sheath surrounding the axoplasm with healthy mitochondria, in
CTR pig (Fig. S4 a-d).
3.4. Severe skeletal muscle pathology is observed in hSOD1G93A Tg pigs
Gross pathologic examination of dissected muscles in symptomatic
end stage Tg pigs revealed multifocal pale areas with irregular borders,
widespread in many skeletal muscles especially in the tongue, dia-
phragm, intercostal, semimembranosus, gastrocnemius, peroneus and
brachialis muscles (Fig. 4), whereas no gross muscular lesions were
visible in CTR animals. Compared to age-matched CTR pigs, micro-
scopic examination revealed severe myopathic changes consisting in a
wide fiber size variability caused by hypertrophy and also atrophy,
internal nuclei, myofiber necrosis, densely stained hypercontracted or
basophilic regenerating fibers and proliferation of endomysial and
perimysial connective tissue (Fig. 4a, b). Secondary inflammatory re-
action characterized by infiltrating macrophages and lymphocytes was
frequently associated with necrosis areas and phagocytosis of fibers
(Fig. 4c, d). Many myofibers had also homogeneous large inclusions of
pale pink material. Moreover, a few angulated atrophic fibers, ring fi-
bers, vacuoles and rare fiber splitting were also visible (Fig. 4e-j) in
symptomatic end stage Tg pigs. However, histochemical reactions for
oxidative enzymes (COX, NADH-TR, SDH) did not reveal any apparent
enzyme deficiency (Fig. 4e-h). Moreover, a normal distribution of gly-
cogen was observed by PAS staining (data not shown). ATPase activity
indicated that both fiber types were involved by lesions, particularly
type II fibers (Fig. 4i, j). By contrast, the cytoarchitecture of extraocular
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muscles was well preserved, as reported for human patients (data not
shown). Semi-thin sections analysis from gastrocnemius muscle showed
unparalleled and disarranged muscle fibers in affected Tg pigs (Fig. 4l),
whereas longitudinal, regular and aligned muscle fibers with the ex-
pected typical banding pattern were detected in parallel sections of CTR
pigs (Fig. 4k).
3.5. Neuromuscular junction denervation and neuropathy are evident in
hSOD1G93A Tg pigs
Immunofluorescence analysis of α-bungarotoxin (BTX) and neuro-
filament was performed and the innervation of motor endplates in
gastrocnemius and peroneus muscles was scored as innervated, par-
tially innervated or denervated (Fig. 5a-c). End stage Tg pigs showed
consistent denervation of the NMJs in the gastrocnemius (24.9%) and
peroneus (25.5%) muscles compared to 6.2% and 13.7% in CTR pigs
(Fig. 5d). In particular, linear mixed model adjusted for muscle tissue
showed a significant increase of the mean denervation percentage
(15.64%, P < .0001, 95% CI 7–24.25%), in gastrocnemius (18.64%,
P= .01, 95% CI 4.47–32.82%) and peroneus (11.83%; P < .0001,
95% CI 6.88–16.77%) muscles in Tg compared to CTR group. No dif-
ferences were observed between Tg and CTR pigs in the percentage of
partially innervated NMJs (P= .528, 95% CI 10.88–21.22%).
The morphology analysis of sciatic nerves showed uniform and
compact axonal fibers in CTR pig, whereas Tg nerve exhibited differ-
ently-sized and smaller fibers, immersed in more abundant endoneurial
tissue (Fig. 5e, f). The g-ratio was significantly different between CTR
and Tg animals (CTR 0.498 ± 0.014 μm vs Tg 0.570 ± 0.014 μm;
P= .005; Fig. 5g). Such results highlight an overall reduction in the Tg
fiber size (CTR 13.3 ± 0.5 μm vs Tg 8.9 ± 0.6 μm; P= .0016),
Fig. 3. MN degeneration and gliosis in end
stage hSOD1G93A Tg pigs spinal cord and
brainstem. (a, b) Representative image of
toluidine blue-stained semithin sections of
lumbar spinal cord ventral horn showing
degenerating motor neuron with darkened
and shrunken cytoplasm in Tg pigs (arrow).
(c, d) Electron microscopy image of a de-
generating MN with nucleolar cavities and
electron dense granules in Tg pig (arrow) as
compared to CTR. (e, f) Representative im-
munostaining of ventral horn MNs showing
normal Golgi apparatus (GA) network in
CTR pig compared to fragmented GA in end
stage Tg pig. (g) Quantification of surviving
motor neurons from CV-stained sections
showing motor neuron loss at different le-
vels of spinal cord in end stage Tg pigs
(n= 2) compared to CTR animals (n=3).
Data are mean ± s.e.m., *P < .05,
***P < .005; by univariate analysis based
on multilevel mixed-effects linear regres-
sion models. (h-k) Representative images of
immunostaining of lumbar spinal cord in
end stage Tg versus CTR pigs for the mi-
croglial marker Iba 1 (h, i) and for the as-
trocytic marker GFAP (j, k). Insets highlight
Iba1 and GFAP positive cells, respectively.
(l, m) Representative immunoblots and
quantitative analysis of Iba1 (l) and GFAP
(n) proteins in cervical (CSc), thoracic
(TSc), lumbar (LSc) and sacral (SSc) spinal
cord samples of Tg and CTR pigs (n=3 per
group). Data are mean ± s.e.m.,
**P < .01, ***P < .005; by univariate
analysis based on multilevel mixed-effects
linear regression models. mBr; mouse brain.
(n, o) Representative H&E staining image of
the brainstem (Brs) showing vacuolization
of motor neurons and neuropil in the dorsal
vagal nerve nuclei in end stage Tg pigs
(arrows). (p, q) Representative images of
peripheral chromatolisis in MNs (arrow in
p) and neuronophagia in the hypoglossal
nerve nuclei (arrows in q) in end stage Tg
animals. (r, s) Representative im-
munostaining of Tg spinal cord (SC) and
brainstem (Brs) for the apoptotic marker
cleaved caspase-3 (arrows). Arrowhead in r
indicate normal healthy MN. Scale bars in
μm are indicated in each photogram. (For
interpretation of the references to colour in
this figure legend, the reader is referred to
the web version of this article.)
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particularly affecting myelin thickness (CTR 6.5 ± 0.2 μm vs Tg
3.8 ± 0.3 μm; P= .0005). Moreover, the fiber size distribution re-
vealed a remarkable shift to lower size in Tg vs CTR pigs, also under-
lining only in the Tg group the presence of a peak at 4–5 μm (P≤ .001)
as a plausible sign of an occurring neuropathy (Fig. 5h) (Riva et al.,
2014).
3.6. hSOD1G93A Tg pigs showed SOD1 aggregates and accumulation
Since cytoplasmic inclusions are a hallmark of ALS, the presence of
protein aggregates was investigated. The anti-human SOD1 (hSOD1)
antibody used did not recognize endogenous swine SOD1 in these ex-
perimental conditions; hSOD1 immunoreactivity was present only in Tg
pigs, where it was intense in spinal cords MN cell bodies (Fig. 6a, b). In
addition, hSOD1 positive skein-like and round inclusions were detected
in the neuropil and within MNs both in the brainstem and spinal cord of
end stage Tg pigs but not in CTRs (Fig. 6c-e). By employing a con-
formation-specific antibody that exclusively detects misfolded SOD1
(SEDI), the presence of positive aggregates was also demonstrated in Tg
pigs (Fig. 6f). Moreover, aberrant accumulation of neurofilaments both
in the Tg brainstem and spinal cord was proved by means of SMI 31 and
Peripherin immunostaining (Fig. S5 a-f). Surprisingly, a prominent
staining of hSOD1 in skeletal muscles was found (Fig. 6g, h). hSOD1
deposition was observed in the cytoplasm of myofibers with a scattered
distribution, mainly as amorphous aggregates (Fig. 6h). By means of the
SEDI antibody, the presence of misfolded hSOD1whithin these muscle
aggregates was confirmed (Fig. 6i, j).
Next, SOD1 protein in the triton-insoluble fraction (TIF) as com-
pared with the soluble fraction from both Tg versus CTR pigs, was
quantified as an index of protein aggregate accumulation in different
CNS areas. Notably, the amounts of the mutant hSOD1 protein were
comparable to that of the endogenous swine protein (sSOD1) (linear
mixed-model, P= .967) and did not vary significantly among several
CNS samples (cortex, cerebellum, striatum, brainstem and spinal cord;
linear mixed-model, P > .1), both in the soluble and insoluble frac-
tions (Fig. 6k). In addition, no differences were observed between Tg
and CTR pigs in the levels of endogenous sSOD1 protein (linear mixed-
model, P= .127). Comparing the levels of soluble and triton-insoluble
protein, the last was higher in Tg pigs, though it was not statistically
significant (linear mixed-model, P > .1).
3.7. TDP-43 levels in PBMCs as a potential biomarker for disease onset
The increase of the TDP-43 protein level in PBMCs parallels the
disease progression in ALS patients (Nardo et al., 2011). Therefore this
biomarker was investigated in symptomatic, asymptomatic hSOD1G93A
Tg pigs and also in CTR pigs. TDP-43 levels were low and comparable
between CTR and Tg pigs that did not develop the disease (Tg 174, 204,
205). In PBMC samples of presymptomatic pigs (Tg 409, Tg 411 and Tg
168), TDP-43 levels were significantly higher than CTR pigs (P < .05).
In particular, in PBMC samples of Tg 168 pig, the TDP-43 began to raise
during the very early presymptomatic stage (from 22 to 25months of
age), doubled its level at 25months of age compared with the asymp-
tomatic and CTR samples, and reached the highest level when the
disease was at the end stage (P < 0,05 versus CTR, asympptomatic and
presymptomstic pigs). In conclusion, the TDP-43 levels raised at least
two months before the onset of the clinical symptoms, opening the
possibility to employ this biomarker to monitor the ALS families even at
presymptomatic stage (Fig. 7). In addition, to further characterize TDP-
43 pathology in the Tg swine model, insoluble TDP-43 in spinal cord
and frontal cortex tissues of Tg pigs (Tg 168, 305, 307) and CTRs, was
measured. As shown in Fig. S6 a, b, the level of TDP-43 in the TIF
Fig. 4. Striking muscle pathology in hSOD1G93A Tg pigs. (a, b) Representative images of transverse sections from CTR and Tg pigs diaphragm stained with H&E. (c, d)
Higher magnification of diaphragm showing fibrosis (c) and myophagocitosis of necrotic fibers (d). (e-j) COX (e, f), NADH-TR (g, h) and ATPase (i, j) staining of
intrinsic muscles of the tongue, semitendinosus and brachialis muscles respectively, in CTR and Tg pigs. (k, l) Representative image of toluidine blue-stained semithin
section of gastrocnemius muscle showing unparalleled and disarranged fibers with infiltrating cells in Tg pig compared to CTR. Scale bars in μm are indicated in each
photogram. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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fraction was higher in Tg than in CTR pigs, although t-test was not
significant (P= .1 for spinal cord and P= .07 for frontal cortex). In-
terestingly, increased levels of insoluble TDP-43 with the same method
were found also in G93ASOD1 mouse models of ALS (Lauranzano et al.,
2015; Marino et al., 2015). Moreover, in cervical spinal cord the levels
of nuclear and cytoplasmic TDP-43 were respectively lower and higher
in Tg 168 than CTR pig (Fig. S7 a, b), indicative of a cytoplasmic
mislocalization of TDP-43, similarly to the G93ASOD1 mouse model
(Lauranzano et al., 2015). Consistently, weaker nuclear TDP-43
staining of large neurons was found in Tg 168 compared to CTR pig,
even if no TDP-43-positive cytoplasmic inclusions were apparent (Fig.
S7 c, d). Nevertheless, the affected SMI-31-positive MN in Tg pigs were
TDP 43 and phospho TDP-43 positive as observed in serial sections (Fig.
S7 e-g).
4. Discussion
In this study, a swine model of familial ALS disease is described. The
expression of the human pathological allele of SOD1 gene with the
G93A mutation caused an ALS like-disease in pigs with an autosomal
mendelian trait. As in humans, the onset of the ALS disease occurs after
a quite long asymptomatic period (about 27months) with full pene-
trance in the progeny of affected transgenic pigs.
According to what reported for ALS mouse models expressing pa-
thological human SOD1 alleles, transgene copy number and expression
level of the pathological protein are critical factors to determine the
severity of the disease (Alexander et al., 2004). Four swine founders
were initially investigated; the Tg 168 founder developed ALS-like
disease at 27months of age, while the others, Tg 174, Tg 204 and Tg
205 (Tg 204-clone) that have lower transgene copy number and low
amount of hSOD1G93A protein, did not develop the clinical phenotype
up to 5 years of age. It cannot be excluded that the latter founders might
develop similar signs and symptoms later, however genetic background,
epigenetic effects on the transgenic integration site, DNA rearrange-
ments or other molecular events may occur and further investigations
are required.
Tg 168 founder developed a neuromuscular disease characterized
by progressive paresis, MN degeneration and gliosis. Cytogenetic and
molecular analysis revealed that the transgenic vector was integrated in
multiple (about 20 copies) tandem-repeat copies in a single site of the
host swine genome on chromosome 2q24. High resolution mapping
allowed to map the chromosome breakpoint at chr2: bp124045533
quite far (about 655 kb and 288 kb at the 5′ and 3′ end of the break-
point, respectively) from known coding genes, supporting the evidence
that no coding genes were interrupted by the integration event. This is
also evident from the genotype analysis of the Tg 168 progeny. Indeed,
the disease is transmitted as an autosomal mendelian trait and the
homozygous Tg 559 pig was born alive and developed the disease
earlier at about 12months of age. A threshold level of pathological
hSOD1G93A seems to be required to trigger the disease by a gain of
function mechanisms, however immunoblot analysis showed compar-
able amounts between transgenic and endogenous SOD1 proteins,
which may reasonable exclude any putative aspecific toxic or artificial
effect due to overexpression of the transgenic protein, such as
squelching, on causing the clinical symptoms. Another transgenic
SOD1G93A pig model was reported by Yang et al. (Yang et al., 2014)
showing hSOD1 expression level lower than or equivalent to the en-
dogenous one; however, in these pigs limb movement defects started as
early as 3months of age. This discrepancy could be dependent on
several factors widely explored in SOD1 mice (i.e. gender, genetic
background); moreover, no transgene integration data were reported
for this model.
From a clinical point of view, Tg pigs showed a long pre-sympto-
matic phase lasting about two years followed by the development of
gait abnormality starting on hind limbs and which progressively wor-
sened with concomitant dysphagia and severe respiratory impairment,
till the humane end point was reached, after approximately four
months. Similarly, in humans, the mutant G93A SOD1 is associated to a
rapid disease progression and more severe neurological symptoms
which last 1 to, at most, 4 years (Kato, 2008); moreover, SOD1 patients
present mostly with limb onset, starting predominantly in lower limb
rather than upper limb. Those cases with worse prognosis present also
with bulbar onset with dysarthria, dysphagia and earlier respiratory
dysfunction due to involvement of the cervical phrenic MNs (Chen
Fig. 5. Tg hSOD1G93A pigs show signs of muscle denervation and peripheral
axonopathy. (a-c) Representative images of neuromuscular junctions (red),
acetylcholine receptor labeled with α- bungarotoxin (BTX), and motor axons
labeled with anti-neurofilament (NF) antibody (green) considered as in-
nervated, partially innervated and denervated. (d) Quantification of the per-
centage of denervation in gastrocnemius and peroneus muscle. Count was
performed in at least 100 NMJs per muscle. Data are mean ± s.e.m., *P < .05,
****P < .0001; by univariate analysis based on multilevel mixed-effects linear
regression models. (e-f) Representative image of toluidine-blue stained sciatic
nerve semithin sections in CTR as compared to Tg pigs. (g) Graph depict the g-
ratio quantification of sciatic nerve fibers in Tg and CTR pigs (n= 3 per group).
Data are mean ± s.e.m., ***P < .005; unpaired t-test. (h) Axon size dis-
tribution in sciatic nerve from CTR and Tg pigs. Scale bars in μm are indicated
in each photogram. (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
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et al., 2013; Swinnen and Robberecht, 2014) underlying that the clin-
ical phenotype in Tg pigs resembled that of ALS patients. In order to
both test muscle activity during gait in awake pigs and to reduce the
invasiveness of the procedure, electrophysiological analysis by sEMG
instead of needle EMG, was performed. A clear pattern of spastic co-
contraction of the gastrocnemius and peroneus muscle in Tg 168 at the
end stage but not in control pigs or other asymptomatic Tg pigs was
observed. Spasticity is reported in patients as a sign of upper motor
neuron involvement; here, the motor cortex role is under investigation.
At disease end-stage, Tg pigs developed key neuropathological
features of ALS including MNs degeneration and loss, gliosis and the
presence of SOD1 positive inclusions. In particular, the number of
surviving MNs was decreased in Tg pigs compared to control pigs in
some areas of the spinal cord, confirming the focal spread of the disease
as observed in patients (Ravits and La Spada, 2009), whereas activated
astrocytes and microglia were increased in association with an increase
of the proinflammatory chemokine MCP-1 which has been demon-
strated to correlate with the disease progression in ALS patient and
mouse model (Guo et al., 2017; Kawaguchi-Niida et al., 2013). Ad-
ditionally, Tg pig showed shrunken and atrophied neuronal cell bodies
with nucleolar alterations. Similar abnormalities were reported as a
sign of degeneration preceding neuronal death (Kiernan and Hudson,
1993) and analogous nucleolar enlargement have been described in a
murine model of Pukinje cell degeneration (Baltanas et al., 2011).
Moreover, although vacuolization pathology is not a common feature in
postmortem tissues of both sporadic ALS (SALS) and familial (FALS)
patients at the end stage (Higgins et al., 2003), SOD1 mice exhibit
abundant vacuoles in neurons and neuropil at the presymptomatic stage
of disease which become less evident at the end stage (Bendotti et al.,
2012; Sumi et al., 2006). Thus, the mild vacuolization pathology ob-
served in the brainstem of Tg pigs may represent an early stage in the
process of neurodegeneration. Another interesting result obtained in Tg
Fig. 6. Mutant SOD1 protein aggregates in hSOD1G93A Tg pigs. (a-d) Representative images of spinal cord ventral horn (a, b) and brainstem motor nuclei (c, d)
revealing intense immunostaining for hSOD1 in motor neurons cell bodies in Tg but not in CTR pigs. (e) Representative image of filamentous and skein-like
aggregates of hSOD1 in brainstem of Tg pigs. (f) Representative images of immunostaining for misfolded hSOD1 (SEDI antibody) in brainstem of Tg pigs. (g-j)
Representative images of immunostaining of peroneus muscle (PeM) in end stage Tg versus CTR pigs showing intense staining for hSOD1 (g, h) and the presence of
aggregates SEDI positive within the fibers (i, j). (k) Representative immunoblot of hSOD1 detected in soluble and triton-insoluble fractions in end stage Tg pig brain
and spinal cord. SC: spinal cord; Brs: brainstem; C: cervical; T: thoracic; L: lumbar; Crb: cerebellum; Cx: cerebral cortex; Str: striatum; hsa: human; sus: porcine. Scale
bars in μm are indicated in each photogram.
Fig. 7. Total TDP-43 protein levels were analyzed by dot blot analysis in PBMC
samples isolated from CTR pigs (C1, C2, 310), Tg founder pigs that did not
develop the disease (Asymp: Tg 204, Tg 205, Tg 174) and Tg pigs that devel-
oped the disease at a presymptomatic (Tg 409, Tg 411, Tg 168) and a symp-
tomatic (Tg 168) stage. CTR (C1: n= 10; C2: n= 15; 310: n=6), Asymp (204:
n= 12, 205: n= 12: 174: n= 12), Presymp (409: n=3; 411: n=2, 168:
n= 4) and Symp (Tg168: n= 3). Data are mean ± s.e.m., of the levels mea-
sured at different time points. Asymptomatic Tg pigs (204, 205, 174) were
analyzed from 22 to 44months of age. Immunoreactivity was normalized to
protein loading, as assessed by Ponceau Red staining (Relative
Immunoreactivity, RI). *P < .05 versus CTRs, #P < .05 versus Asymp and
Presymp, by one-way ANOVA, Tukey's multiple comparisons test.
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pigs is the presence of MNs Cleaved Caspase 3, a final effector of
apoptotic cell death, but none TUNEL-positive cells. Even if there is
compelling evidence indicating that MN death in ALS patients and
SOD1G93A mice does not occur through apoptosis (He and Strong, 2000;
Migheli et al., 1999), a toxic cascade characterized by the sequential
activation of Caspase 1 and Caspase 3 has been implicated in the vul-
nerability of MNs in ALS (Pasinelli et al., 2000). Our results in Tg pigs
confirm previous findings in ALS mice, suggesting that caspase activa-
tion is a feature of neurodegenerative processes associated to mutant
SOD1 but MN death do not occur through apoptosis. The evaluation of
the autophagy pathway revealed a huge increase in the number of LC3-
positive vesicles in Tg ventral horn MNs suggesting a likely dysfunction
of the autophagic system in Tg swine model; a similar upregulation of
autophagic markers has been already reported in several ALS murine
models and in human patients (Nguyen et al., 2018; Song et al., 2012).
Tg pigs showed loss of the normal network of elements of the Golgi
Apparatus (GA), which appeared dispersed and isolated in most of the
remaining spinal MNs. The fragmentation of the GA was frequently
observed in patients with sporadic, familial and juvenile ALS and in
SOD1G93A Tg mice appears long before the onset of disease suggesting
that it is an early sign of neuronal degeneration (Fujita and Okamoto,
2005). Moreover, it was suggested that GA fragmentation could be re-
lated to the presence of protein aggregates which were detected in our
Tg pigs, contrary to that was previously reported in a similar hSOD1 pig
model (Yang et al., 2014). Protein aggregates represent a hallmark of
ALS in humans, appearing as intracytoplasmic eosinophilic inclusions
(Bunina bodies) or as round ialine and skein like inclusions (Blokhuis
et al., 2013). In brainstem neurons and neuropil of our Tg pigs we found
both round and skein-like inclusions which were immunopositive for
hSOD1 and most importantly, for the misfolded form of SOD1. There-
fore, altogether these data suggest the validity of Tg pigs as a useful
model to study certain etiopathogenetic aspects (e.g. protein misfolding
and aggregation) in ALS.
Particularly striking in our Tg pig model is the muscular pathology
characterized by necrosis and inflammation associated to a massive
deposition of the human SOD1 protein, NMJ denervation and distal
axonopathy. Acute or chronic neurogenic atrophy and mitochondria
dysfunction are common findings in muscle biopsies of FALS and SALS
patients and similarly Tg SOD1 mice. Our results in Tg pigs at the end
stage revealed a pattern resembling a muscular dystrophy rather than a
mere denervation atrophy with the presence of several degrees of in-
flammation, necrosis and fibrosis. This severe muscular pathology
could be due to the elevated expression of mutant SOD1 in skeletal
muscles of our Tg pigs. Wong et al. (Wong and Martin, 2010) demon-
strated that hSOD1 toxicity to skeletal muscles involves oxidative da-
mage and nitrative stress but it is independent of the formation of SOD1
aggregates. Nevertheless, the role of mutant SOD1 aggregates in im-
pairing protein conformation and the consequent muscle loss in ALS
remains elusive (Wei et al., 2012). To our knowledge, there are no re-
ports regarding SOD1 aggregation in ALS patient muscles, however, the
presence of dystrophic-like changes in Tg pigs suggests that mutant
SOD1 might contributes to muscle degeneration. Substantial evidence
indicates that the pathological process leading to ALS involves multiple
cell types, including skeletal muscle cells. In particular, different studies
demonstrated in both ALS patients and animal models, defects in the
skeletal muscle that occur even in the absence of motor neuron death,
supporting the “dying-back” hypothesis in which distal motor endplate
degeneration plays a key role in the progression of the disease (Dupuis
and Loeffler, 2009; Fischer et al., 2004; Musaro, 2013; Rocha et al.,
2013). Selective expression of mutant SOD1 in mouse skeletal muscles
under the transcriptional control of muscle-specific promoter (MLC)
induced progressive muscle atrophy, reduction in muscle strength and
mitochondrial dysfunction without MN degeneration (Dobrowolny
et al., 2008). On the contrary, another study reported that the expres-
sion of mutant SOD1 in skeletal muscles causes MN degeneration as a
later event after muscle pathology (Wong and Martin, 2010). Thus,
although initially the “neurocentric” dogma assumed that MN degen-
eration, caused by mutant SOD1, was the main driver of muscular
atrophy, more recent evidence suggests that muscular dysfunction
could precede and contribute in triggering MN degeneration (Fischer
et al., 2004; Frey et al., 2000; Moloney et al., 2014). Consistently, we
found that Tg pigs displayed marked signs of distal axonopathy and
denervation in the gastrocnemius and peroneus muscles despite of the
lack of a significant loss of MNs in the lumbar spinal cord. Further
studies involving animals at different stage of disease (e.g. early, mid
and late symptomatic) are requested.
Notably, we have also found that Tg pigs that develop the disease
has a higher total TDP-43 protein level in PBMCs than CTR and
asymptomatic Tg controls, similarly to ALS patients (Filareti et al.,
2017; Nardo et al., 2011) thus confirming the robustness of the pa-
thological phenotype of this animal model. Moreover, we demonstrated
that total TDP-43 protein level is an early disease biomarker, since it
underscores disease also before overt clinical symptoms, an aspect that
could not be explored in the patients. Interestingly, in this respect the
Tg pig model is more similar to the patients than to the SOD1G93A
mouse model in which we could not find higher TDP-43 levels in
PBMCs compared to CTRs (Filareti et al., 2017).
In conclusion, altogether our data demonstrated that Tg pigs might
represent a similar and representative model of human ALS and thus
offer several advantages compared to rodents such as the possibility to
study the etiopathogenetic events that precede the onset of disease and
potential diagnostic and prognostic biomarkers. Furthermore, the
longer symptomatic phase and the large size might allow to test for
novel drugs and possible advanced therapy medicinal products.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nbd.2018.11.021.
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